2022
DOI: 10.1007/s40200-022-01120-1
|View full text |Cite
|
Sign up to set email alerts
|

Stem cell therapy for type 1 diabetes: a scientometric assessment of global research during the twenty-first century

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 36 publications
0
3
0
Order By: Relevance
“…We also found that the CHO research is dominated by high-income countries of Western Europe and North America, similar to previous global mapping studies. [18][19][20] This reflects the governmental commitment, the availability of infrastructure, and funding in high-income countries that enables conducting highly organized research endeavors in any field of science. 30 In contrast, research in low-and middle-income countries remains disorganized and poorly funded, resulting in low-impact publications.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We also found that the CHO research is dominated by high-income countries of Western Europe and North America, similar to previous global mapping studies. [18][19][20] This reflects the governmental commitment, the availability of infrastructure, and funding in high-income countries that enables conducting highly organized research endeavors in any field of science. 30 In contrast, research in low-and middle-income countries remains disorganized and poorly funded, resulting in low-impact publications.…”
Section: Discussionmentioning
confidence: 99%
“…The search strategy was identical to our previous bibliometric studies. [18][19][20] The leading search strategy yielded 37,762 global CHO records, further refined by countries, authors, organizations, and journals. The publications were quantified using the complete counting technique, i.e., each contributing author or organization in multiple authorship papers was fully counted and given equal credit.…”
Section: Methodsmentioning
confidence: 99%
“…Our analysis revealed that the COVID-19 related mucormycosis research was mainly carried out in the low-and middle-income countries, unlike research in several other medical fields during COVID-19 pandemic or even during pre-COVID-19 times, which shows domination by highincome countries of North America or Western Europe. [21][22][23][24][30][31][32] This is understandable as the low-or middle-income countries were particularly hit by the dual burden of COVID-19 and CAM. 6,7 But even while the productivity of organizations and authors from low-and middle-income countries was substantial, it was the high-income countries such as France and the USA that led in CAM research impact.…”
Section: Discussionmentioning
confidence: 99%